Cristina Rebordosa (Tania Schink, T Schink)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Clinical Practice

Major Depressive Disorder

Top Venues

Pharmacoepidemiology and drug safety

International journal of chronic obstructive pulmonary disease

BJOG : an international journal of obstetrics and gynaecology

This page only lists publications with an associated author ORCID identifier.

Publications

Edeltraut Garbe, Fabian Hoti, Cristina Rebordosa, Kristian Svendsen, Haydar Al-Eid, Per Arkhammar, Marie Carlholm, Harald Fjällbrant, Stefan Franzén, Cecilia Hedlund, Bianca Kollhorst, Atul Kumar, Muriel Lobier, Vasili Mushnikov, Tore Persson, Xu Qiao, Aaro Salosensaari, Wiebke Schäfer, Nicholas M Sicignano, Gunnar Johansson, Eileen O Dareng
Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Edeltraut Garbe, Fabian Hoti, Cristina Rebordosa, Kristian Svendsen, Haydar Al-Eid, Per Arkhammar, Marie Carlholm, Harald Fjällbrant, Stefan Franzén, Cecilia Hedlund, Bianca Kollhorst, Atul Kumar, Muriel Lobier, Vasili Mushnikov, Tore Persson, Xu Qiao, Aaro Salosensaari, Wiebke Schäfer, Nicholas M Sicignano, Gunnar Johansson, Eileen O Dareng
Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Edeltraut Garbe, Fabian Hoti, Cristina Rebordosa, Kristian Svendsen, Haydar Al-Eid, Per Arkhammar, Marie Carlholm, Harald Fjällbrant, Stefan Franzén, Cecilia Hedlund, Bianca Kollhorst, Atul Kumar, Muriel Lobier, Vasili Mushnikov, Tore Persson, Xu Qiao, Aaro Salosensaari, Wiebke Schäfer, Nicholas M Sicignano, Gunnar Johansson, Eileen O Dareng
Long-Term Safety of Roflumilast in Patients with Chronic Obstructive Pulmonary Disease, a Multinational Observational Database Cohort Study. International journal of chronic obstructive pulmonary disease 19 (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Gunnar Brobert, Ana Ruigomez, Cristina Rebordosa, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin M A Swart, Leif Friberg, Yanina Balabanova, Christine Tarenz, Kiliana Suzart-Woischnik, Montse Soriano Gabarró, Pareen Vora, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya, Luis Alberto García-Rodríguez
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe. BMJ open 14 (3) (2024)
Luis Alberto García-Rodríguez, Ana Ruigómez, Cristina Rebordosa, Annemarie Voss, Elisabeth Smits, Karin M A Swart, Yanina Balabanova, Kiliana Suzart-Woischnik, Gunnar Brobert, Ron M C Herings
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries. Expert opinion on drug safety (2023)
Cristina Rebordosa, Malte Braitmaier, U Haug
Authors' reply. BJOG : an international journal of obstetrics and gynaecology (2023)
Katharina Platzbecker, Helge Müller-Fielitz, Ronja Foraita, Matthias J Koepp, Annemarie Voss, René Pflock, Roland Linder, Iris Pigeot, Cristina Rebordosa, Markus Schwaninger
In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Annemarie Voss, Elisabeth Smits, Karin M A Swart, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ron M C Herings, Cristina Rebordosa, Ulrike Haug
Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands. Drugs - real world outcomes (2023)
Cristina Rebordosa, Christina Princk, Malte Braitmaier, Ulrike Haug
Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data. BJOG : an international journal of obstetrics and gynaecology 129 (13) (2022)
Elisabeth Smits, Felicita Andreotti, Eline Houben, Harry J G M Crijns, Sylvia Haas, George Spentzouris, Cristina Rebordosa, Rosa Gini, Claudia Bartolini, Fernie J A Penning-van Beest, Ron Herings
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany. Drugs - real world outcomes 9 (2) (2022)
Ulrike Haug, Bianca Kollhorst, Cristina Rebordosa, Kathrin Thöne, Katarina Dathe, Christof Schaefer, Marlies Onken
Investigating drug safety in pregnancy based on the German Pharmacoepidemiological Research Database (GePaRD): A proof-of-concept analysis on the association between valproate and spina bifida. Pharmacoepidemiology and drug safety (2022)
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z Daoud, Alejhandra Lei, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Jesper Hallas, Cristina Rebordosa, Cristina Rebordosa
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical drug investigation 42 (4) (2022)
Katharina Platzbecker, Annemarie Voss, Jonas Reinold, Anne Elbrecht, Wolfgang Biewener, Daniel Prieto Alhambra, Annika M Jödicke, Cristina Rebordosa
Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance Data. Clinical epidemiology 14 (2022)
Joan Fortuny, Gero von Gersdorff, Régis Lassalle, Marie Linder, Jetty A Overbeek, Jonas Reinold, Gunnar Toft, Antje Timmer, Jochen Dress, Patrick Blin, Cécile Droz-Perroteau, Vera Ehrenstein, Carla Franzoni, Ron M C Herings, Bianca Kollhorst, Nicholas Moore, Ingvild Odsbu, Susanna Perez-Gutthann, Cristina Rebordosa, Katherine Rascher, Lawrence Rasouliyan, Kenneth J Rothman, Nuria Saigi-Morgui, Mathias Schaller, Elisabeth Smits, Michael Forstner, null null, Jacques Benichou, Andreas J Bircher, Edeltraut Garbe, David S Rampton, Lia Gutiérrez
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe. Pharmacoepidemiology and drug safety 30 (10) (2021)
Dominik de Sordi, Sanny Kappen, Fabian Otto-Sobotka, Anke Kulschewski, Andreas Weyland, Lia Gutierrez, Joan Fortuny, Jonas Reinold, Cristina Rebordosa, Antje Timmer
Validity of hospital ICD-10-GM codes to identify anaphylaxis. Pharmacoepidemiology and drug safety 30 (12) (2021)
Federica Edith Pisa, Jonas Reinold, Bianca Kollhorst, Ulrike Haug, Cristina Rebordosa
Individual Antidepressants and the Risk of Fractures in Older Adults: A New User Active Comparator Study. Clinical epidemiology 12 (2020)
Luis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg, Ana Ruigómez, Cristina Rebordosa, Irene D Bezemer, Ron M C Herings, Saad Shakir, Alison Evans, Miranda Davies, Kiliana Suzart-Woischnik, Pareen Vora, Yanina Balabanova, Montse Soriano Gabarró, Gunnar Brobert
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice. Expert opinion on drug safety 19 (11) (2020)
Wiebke Schäfer, Christina Princk, Bianca Kollhorst, Cristina Rebordosa
Antidepressants and the Risk of Hemorrhagic Stroke in the Elderly: a Nested Case-Control Study. Drug safety 42 (9) (2020)
Bianca Kollhorst, Kathrin Jobski, Jutta Krappweis, Cristina Rebordosa, Edeltraut Garbe, Niklas Schmedt
Antidepressants and the risk of death in older patients with depression: A population-based cohort study. PloS one 14 (4) (2019)
Antje Timmer, Dominik de Sordi, Sanny Kappen, Klaus Peter Kohse, Cristina Rebordosa, Susanna Perez-Gutthann, Emmanuelle Jacquot, Nicolas Deltour, Manel Pladevall
Validity of hospital ICD-10-GM codes to identify acute liver injury in Germany. Pharmacoepidemiology and drug safety 28 (10) (2019)
Cristina Rebordosa, Bianca Kollhorst, Cristina Varas Lorenzo, Andrea Arfè, Ron Herings, Silvia Lucchi, Silvana Romio, René Schade, Martijn J Schuemie, Huub Straatman, Vera Valkhoff, Marco Villa, Miriam Sturkenboom, Edeltraut Garbe
Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project. PloS one 13 (9) (2018)